{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-12T12:28:27.465516+00:00",
  "news": [
    {
      "title": "Amgen Buys U.K. Biotech Company - Los Angeles Business Journal",
      "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE15akFRZGx1THlXTF9lWmFyWWQ5SW9FbFpEaXYwMnlqcFkzR1dra1Frbjg2NXZMMDdLcUdhallQTHd3Ujdod0p6b1IzbkZGTWpUTVZoQTVyLTBEaHpGUlJlOWdGNG5MSVNFRktDVVpvT01XRzFEbEhHVFE5Ylk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTE15akFRZGx1THlXTF9lWmFyWWQ5SW9FbFpEaXYwMnlqcFkzR1dra1Frbjg2NXZMMDdLcUdhallQTHd3Ujdod0p6b1IzbkZGTWpUTVZoQTVyLTBEaHpGUlJlOWdGNG5MSVNFRktDVVpvT01XRzFEbEhHVFE5Ylk?oc=5\" target=\"_blank\">Amgen Buys U.K. Biotech Company</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Los Angeles Business Journal</font>",
      "published": "2026-01-12T08:32:52+00:00",
      "source": "Los Angeles Business Journal"
    },
    {
      "title": "Amgen dances with Disco in $618M cancer target pact - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNWU1uUGRZSGdPc3pXNTRlZlltUndFQ1JRdnZNYWozbS12RWYxa3RCa0taQ3NJUVZhMGhKa09zOWJpY1N6OENMSGt5VUJEUUxhSmM4R0lQQjNKOGRudy1kM2tKUGQ5Tzc0MHBCQmJzX3IwWTI0eEFLUTY2RWIxZ3hnQVQ1djVmSzg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNWU1uUGRZSGdPc3pXNTRlZlltUndFQ1JRdnZNYWozbS12RWYxa3RCa0taQ3NJUVZhMGhKa09zOWJpY1N6OENMSGt5VUJEUUxhSmM4R0lQQjNKOGRudy1kM2tKUGQ5Tzc0MHBCQmJzX3IwWTI0eEFLUTY2RWIxZ3hnQVQ1djVmSzg?oc=5\" target=\"_blank\">Amgen dances with Disco in $618M cancer target pact</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2026-01-07T15:15:45+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "First Horizon Corp Takes Position in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPQlpCaGEwb3BuY2pMVzN3R2RuWExMdW1hamtMREhkdHRSWVF4QW53UXRSZlZhY1pScWw2dEtXYXpVaGR3QnRKaTloUlpqQVdtU0NpMUt0d3Q2Uk9SVUdqQ0NWODYxMnZTMW16Tk9pZXVCWThncDNlNHhlT1FtZ1FLQjN5N3BrMU94R2JvSjJSVnE1dkpZb0w0SXpBRzlOMGZPbHhkWUVTNzM3RHdwYUN0bXpR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPQlpCaGEwb3BuY2pMVzN3R2RuWExMdW1hamtMREhkdHRSWVF4QW53UXRSZlZhY1pScWw2dEtXYXpVaGR3QnRKaTloUlpqQVdtU0NpMUt0d3Q2Uk9SVUdqQ0NWODYxMnZTMW16Tk9pZXVCWThncDNlNHhlT1FtZ1FLQjN5N3BrMU94R2JvSjJSVnE1dkpZb0w0SXpBRzlOMGZPbHhkWUVTNzM3RHdwYUN0bXpR?oc=5\" target=\"_blank\">First Horizon Corp Takes Position in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-12T09:48:54+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-01-06T14:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen buys protein-degrading startup Dark Blue for up to $840M - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQajF5MUNsd0IyX1V1RTlGZE10UDhCQWNRWkZOTXRlcHZMa1Z3ODdqNkRidW5RLURnWFl4QWpkbkI2RnllLV9uVEk5bTVWNUdjSE1hQWJkU0NyM2NlVDlmRkt5aE9hbGtHSE40MVFudzdTb2QtdjIwWW9pMDhPbVhKVjF1T2ZOcGw0RVgzT2lVTDY0RXdYNnFzWjdKRkJZdEg5eXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxQajF5MUNsd0IyX1V1RTlGZE10UDhCQWNRWkZOTXRlcHZMa1Z3ODdqNkRidW5RLURnWFl4QWpkbkI2RnllLV9uVEk5bTVWNUdjSE1hQWJkU0NyM2NlVDlmRkt5aE9hbGtHSE40MVFudzdTb2QtdjIwWW9pMDhPbVhKVjF1T2ZOcGw0RVgzT2lVTDY0RXdYNnFzWjdKRkJZdEg5eXc?oc=5\" target=\"_blank\">Amgen buys protein-degrading startup Dark Blue for up to $840M</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2026-01-06T16:48:14+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Amgen inks $840m takeover of UK's Dark Blue Therapeutics - Pharmaphorum",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb2pxbHltVkJOVWNHYUxqdW9STXZxdHZNYlRTeFZ4Z1ZpdGVNczlQS21kaktncU5uSHMyR1VXWTJKLVlDUFpVejhPcXdJUVhrU1RBVi1tVE9WbUpsWWt6S0hGTGJ6YmY1M3dlUmRyaTNYcjUxNDcxUzE5VEJLVmRhOVEwcS1UT2tv?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb2pxbHltVkJOVWNHYUxqdW9STXZxdHZNYlRTeFZ4Z1ZpdGVNczlQS21kaktncU5uSHMyR1VXWTJKLVlDUFpVejhPcXdJUVhrU1RBVi1tVE9WbUpsWWt6S0hGTGJ6YmY1M3dlUmRyaTNYcjUxNDcxUzE5VEJLVmRhOVEwcS1UT2tv?oc=5\" target=\"_blank\">Amgen inks $840m takeover of UK's Dark Blue Therapeutics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharmaphorum</font>",
      "published": "2026-01-06T15:40:29+00:00",
      "source": "Pharmaphorum"
    },
    {
      "title": "Amgen buys Dark Blue Therapeutics in $840m oncology deal - Pharmaceutical Technology",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxONGkwYmdDcHRjUnVDVlQ0eXpRWlV6eVczU29UekZpcndSNC1yUDh6TUJVLTJFS2tVaXFfbUljSFFfR2g3ZXJxazFuRUlWUXpidFg2VDlsak5HYkEwY3FiVkFTYUw3OVVRZEhCMjBBZFpSUXBHS3R3cGZJUEI1Vk5la2JlQWhHN0kzbS1BNUM0SXhYZHJLTnRBdzFaX3FKaVVNeE9rN1FwZjRYMi03RGVOejgzZDlETGNDYTdZbA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxONGkwYmdDcHRjUnVDVlQ0eXpRWlV6eVczU29UekZpcndSNC1yUDh6TUJVLTJFS2tVaXFfbUljSFFfR2g3ZXJxazFuRUlWUXpidFg2VDlsak5HYkEwY3FiVkFTYUw3OVVRZEhCMjBBZFpSUXBHS3R3cGZJUEI1Vk5la2JlQWhHN0kzbS1BNUM0SXhYZHJLTnRBdzFaX3FKaVVNeE9rN1FwZjRYMi03RGVOejgzZDlETGNDYTdZbA?oc=5\" target=\"_blank\">Amgen buys Dark Blue Therapeutics in $840m oncology deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharmaceutical Technology</font>",
      "published": "2026-01-07T12:05:13+00:00",
      "source": "Pharmaceutical Technology"
    },
    {
      "title": "2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOcWprWDR1WDBZZHhaOHM3NVBFRXlsd3d2UTRQQjU2cnlmS2hkVEFSb1lJX3A1dUlvbnZrRVZ1N0lXTXJsWGVNeWRXZ0d1T0t0Z0F0d2g3RzlWOXRnM1Ffa3FhVTloLW5yNmMzcGNCWURtN3ZBVU1lT0RING5tc3cxX284Z2JBVk14VlREWDJlRDF4MS1weHBtU2tzYlRvZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOcWprWDR1WDBZZHhaOHM3NVBFRXlsd3d2UTRQQjU2cnlmS2hkVEFSb1lJX3A1dUlvbnZrRVZ1N0lXTXJsWGVNeWRXZ0d1T0t0Z0F0d2g3RzlWOXRnM1Ffa3FhVTloLW5yNmMzcGNCWURtN3ZBVU1lT0RING5tc3cxX284Z2JBVk14VlREWDJlRDF4MS1weHBtU2tzYlRvZw?oc=5\" target=\"_blank\">2025 at Amgen: Investing, Expanding, and Serving More Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-17T08:00:00+00:00",
      "source": "Amgen"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-09",
      "close": 326.1000061035156
    },
    "history": [
      {
        "date": "2025-12-31",
        "close": 327.30999755859375
      },
      {
        "date": "2026-01-02",
        "close": 327.6400146484375
      },
      {
        "date": "2026-01-05",
        "close": 320.7200012207031
      },
      {
        "date": "2026-01-06",
        "close": 330.1700134277344
      },
      {
        "date": "2026-01-07",
        "close": 341.6400146484375
      },
      {
        "date": "2026-01-08",
        "close": 330.1099853515625
      },
      {
        "date": "2026-01-09",
        "close": 326.1000061035156
      }
    ],
    "name": "Amgen Inc."
  }
}